Your browser is no longer supported. Please, upgrade your browser.
Settings
NVO Novo Nordisk A/S daily Stock Chart
NVO [NYSE]
Novo Nordisk A/S
Index- P/E16.93 EPS (ttm)2.10 Insider Own26.40% Shs Outstand1.97B Perf Week0.03%
Market Cap70.03B Forward P/E15.82 EPS next Y2.25 Insider Trans0.00% Shs Float1.26B Perf Month0.03%
Income5.35B PEG1.92 EPS next Q0.50 Inst Own9.70% Short Float0.25% Perf Quarter-12.15%
Sales15.86B P/S4.42 EPS this Y34.30% Inst Trans-0.36% Short Ratio0.80 Perf Half Y-34.95%
Book/sh2.33 P/B15.29 EPS next Y3.59% ROA42.90% Target Price35.10 Perf Year-30.79%
Cash/sh1.20 P/C29.59 EPS next 5Y8.80% ROE89.20% 52W Range30.89 - 57.26 Perf YTD-0.64%
Dividend1.41 P/FCF33.22 EPS past 5Y22.40% ROI85.00% 52W High-37.78% Beta0.81
Dividend %3.96% Quick Ratio0.90 Sales past 5Y12.20% Gross Margin84.80% 52W Low15.34% ATR0.55
Employees42605 Current Ratio1.20 Sales Q/Q2.80% Oper. Margin43.50% RSI (14)51.55 Volatility1.15% 1.13%
OptionableYes Debt/Eq0.01 EPS Q/Q18.80% Profit Margin33.70% Rel Volume0.36 Prev Close36.04
ShortableYes LT Debt/Eq0.00 EarningsFeb 02 BMO Payout43.30% Avg Volume3.96M Price35.63
Recom4.00 SMA20-0.69% SMA502.75% SMA200-22.60% Volume1,439,250 Change-1.14%
Oct-31-16Downgrade DNB Markets Buy → Hold
Oct-31-16Downgrade Citigroup Buy → Neutral
Oct-28-16Downgrade BofA/Merrill Neutral → Underperform
Sep-23-16Initiated Piper Jaffray Neutral
Sep-13-16Upgrade Exane BNP Paribas Neutral → Outperform
Sep-09-16Downgrade JP Morgan Overweight → Neutral
Sep-01-16Downgrade Morgan Stanley Overweight → Equal-Weight
Aug-31-16Upgrade HSBC Securities Reduce → Hold
Aug-08-16Downgrade BofA/Merrill Buy → Neutral
Aug-28-15Initiated Leerink Partners Mkt Perform $56
Jun-09-15Upgrade Morgan Stanley Equal-Weight → Overweight
Apr-15-15Initiated Societe Generale Sell
May-28-13Upgrade Deutsche Bank Sell → Hold
Mar-31-10Initiated Deutsche Bank Hold
Mar-30-10Downgrade Mehta Partners Outperform → Market Perform
Feb-24-10Upgrade Jefferies & Co Hold → Buy
Jan-15-10Downgrade Jefferies & Co Buy → Hold
Sep-11-09Initiated Jefferies & Co Buy
Aug-07-09Downgrade UBS Buy → Neutral
Aug-07-09Downgrade JP Morgan Overweight → Neutral
Jan-17-17 11:48AM  NVO SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Novo Nordisk A/S and a Lead Plaintiff Deadline of March 13, 2017 GlobeNewswire
Jan-16-17 10:10AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Novo Nordisk A/S (NVO) and Lead Plaintiff Deadline: March 13, 2017 GlobeNewswire
09:07AM  How Did Novartis Perform in 3Q16?
Jan-13-17 10:50PM  NOVO NORDISK SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Novo Nordisk A/S (NVO) GlobeNewswire
02:20PM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Novo Nordisk A/S (NVO) and Lead Plaintiff Deadline: March 13, 2017 Accesswire
11:19AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVO PR Newswire
Jan-12-17 10:40PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Novo Nordisk A/S NVO Business Wire
08:00PM  SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Novo Nordisk A/S (NVO) To Contact Brower Piven Before The Lead Plaintiff Deadline GlobeNewswire
03:25PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Novo Nordisk A/S of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 13, 2017 NVO GlobeNewswire
03:07PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Novo Nordisk A/S (NVO) and Lead Plaintiff Deadline: March 13, 2017 Accesswire
03:01PM  2 MONTHS REMAIN FOR NOVO NORDISK A/S INVESTORS: Hagens Berman Alerts Novo Nordisk Investors to Securities Class Action and Lead Plaintiff Deadline GlobeNewswire
12:20PM  Drug makers, auto stocks yank European stocks lower for first time in 3 days at MarketWatch
10:15AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Novo Nordisk A/S (NVO) and Lead Plaintiff Deadline: March 13, 2017 PR Newswire
08:42AM  Stock Futures Hold Lower as Jobless Claims, Import Prices Rise
04:55AM  Novo Nordisk shares hit by U.S. lawsuit, Trump comments
04:45AM  Novo Nordisk slumps 5.4% on U.S. price fixing lawsuit at MarketWatch
Jan-11-17 07:29PM  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Novo Nordisk A/S To Contact The Firm Before Lead Plaintiff Deadline GlobeNewswire
05:59PM  Bernstein Litowitz Berger & Grossmann LLP Announces Securities Class Action Suit Filed Against Novo Nordisk A/S and Certain of its Senior Executives PR Newswire
08:27AM  Novo Nordisk (NVO) Fiasp Gets EU Nod for Diabetes in Adults
Jan-09-17 01:53PM  ETFs with exposure to Novo Nordisk A/S : January 9, 2017
Jan-07-17 10:53AM  In the age of Uber and Lyft, its still hard for some Americans to get to the doctor at MarketWatch
Jan-05-17 05:42PM  Top 7 Dividend Health Care Stocks
Dec-30-16 03:53PM  Here's What Good Managers Do When Things Don't Go Their Way at Forbes
12:05PM  AstraZenecas Focused Strategy to Boost Future Revenues
Dec-28-16 03:43PM  Sanofi SA (ADR) (SNY) Files Suit Against Novo Nordisk A/S (ADR) (NVO) Over False Insulin Claims at Insider Monkey
Dec-27-16 01:33PM  ETFs with exposure to Novo Nordisk A/S : December 27, 2016
11:36AM  Sanofi sues Novo Nordisk over diabetes drugs in the U.S.
10:52AM  New Strong Sell Stocks for December 27th
Dec-26-16 09:06AM  Novo Nordisk A/S :NVO-US: Earnings Analysis: Q3, 2016 By the Numbers : December 26, 2016
Dec-25-16 06:03AM  January is the cruelest month for pharmacists at MarketWatch
Dec-23-16 12:41PM  Something Strange Is Going On With Oral Insulin
Dec-22-16 03:29PM  Moody's Assigns Definitive Ratings to Eight CMBS Classes of CSMC 2016-NXSR at Moody's
Dec-21-16 03:30PM  JoCo anticipates economic boost from construction crews at $2B Novo Nordisk plant at bizjournals.com
Dec-20-16 08:25PM  Jim Cramer's 'Mad Money' Recap: Animal Spirits Are on the Prowl
09:50AM  3 Dividend Stocks to Buy on Sale at Motley Fool
Dec-15-16 10:58AM  A cheaper version of the lifesaving diabetes medication just launched in the US
10:00AM  3 European Stocks to Buy for Big-Time Dividends at Kiplinger
09:47AM  A Primer On NASH
12:23AM  Is SAP AG (ADR) (SAP) Going to Burn Investors? at Insider Monkey
Dec-14-16 08:09AM  Eli Lilly (LLY) to Offer Discount on Insulin from January
Dec-13-16 10:15AM  Some people spend as much on insulin as their mortgage and drugmakers are taking note
08:07AM  Lilly (LLY) Gets FDA Nod for Once-Daily Version of Synjardy
Dec-09-16 09:31AM  Emisphere Restructures Debt Agreements, Providing Greater Stability for Business Growth and Expansion GlobeNewswire
Dec-08-16 08:51PM  Moody's Assigns Provisional Ratings to Eight CMBS Classes of CSMC 2016-NXSR at Moody's
12:44PM  10 Largest Hedge Funds in The World And Their Favorite Stock Picks at Insider Monkey
Dec-07-16 05:02PM  Trump Warns Investors "I'm Going To Bring Down Drug Prices" at Motley Fool
08:18AM  Better Buy: MannKind Corp. vs. Novo Nordisk at Motley Fool
12:19AM  Business Watch at The Wall Street Journal
Dec-06-16 07:32PM  [$$] Business Watch at The Wall Street Journal
03:04PM  Novo Nordisk Pledges to Limit Price Increases in U.S. for Its Drugs at The Wall Street Journal
08:19AM  Novo Nordisk Files Regulatory Application for Semaglutide
08:13AM  A second major drugmaker says it will cap price increases
Dec-05-16 05:55PM  A second major drugmaker just committed to limiting price increases
02:38PM  Novo's Pricing Pledge Is a Sign of More to Come at Bloomberg
09:42AM  Novo Nordisk Files for Regulatory Approval of Once-Weekly Semaglutide with the FDA for the Treatment of Type 2 Diabetes PR Newswire
02:30AM  Novo Nordisk A/S (ADR) (NVO)Hedge Funds Are Snapping Up at Insider Monkey
Dec-01-16 04:50PM  These drug and medical device companies made $5.6 million in nonresearch payments to Washington hospitals last year at bizjournals.com
Nov-30-16 11:21AM  [$$] Novo Nordisk shares rally on insulin trial results at Financial Times
10:49AM  3 High-Yield Dividend Stocks to Buy in December at Motley Fool
10:04AM  Novo Nordisk's Tresiba Shows Safe Cardiovascular Profile
Nov-29-16 07:22PM  Novo's New Insulin Reduces Risk of Low Blood Sugar, Study Shows at The Wall Street Journal
02:13PM  Novo Nordisk reports Tresiba insulin achieves target in study Reuters
Nov-28-16 09:49AM  New Strong Sell Stocks for November 28th
Nov-25-16 06:09PM  Do Hedge Funds Love Cisco Systems, Inc. (CSCO)? at Insider Monkey
01:14PM  Gurus Invest in Undervalued Biotech Stocks
12:43PM  [$$] Novo Nordisk: shot in the dark at Financial Times
Nov-23-16 11:03AM  US FDA Approves Sanofi SA (ADR) (SNY) Soliqua 100/33, Novo Nordisk A/S (ADR) (NVO) Xultophy 100/3.6 at Insider Monkey
09:13AM  Novo Nordisk's Diabetes Combination Drug Gets FDA's Nod
Nov-22-16 04:04PM  AstraZeneca, Novartis Drop into Tuesdays 52-Week Low Club
02:50PM  FDA Approves Novo Nordisk Diabetes Drug (NVO) at Investopedia
02:16PM  Dueling Diabetes Duos Won't End Price Pressure at Bloomberg
Nov-21-16 04:04PM  Pilgrims Pride, Sunoco Slide into Mondays 52-Week Low Club
11:21AM  23 Questions With Thomas Macpherson of Nintai Partners
Nov-18-16 04:04PM  Infosys, Nielsen Dip into Fridays 52-Week Low Club
Nov-16-16 07:07AM  [$$] US casts shadow on Novo Nordisk ahead of 'perfect storm' at Financial Times
Nov-14-16 09:19AM  5 Pharma Stocks in Focus on World Diabetes Day
08:05AM  One World Trade Center to Glow Blue in Honor of World Diabetes Day Tonight PR Newswire
Nov-11-16 08:39AM  Why Novo Nordisk A/S Stock Dropped 13.6% in October at Motley Fool
Nov-10-16 12:58PM  MannKind Is Still Too Heavy to Avoid the Afrezza Crash Landing
09:30AM  The Zacks Analyst Blog Highlights: Chevron, Glaxo, Aflac, Novo Nordisk and MGM Resorts
02:37AM  Pharma stocks propel European stocks higher after Trump win shakes markets at MarketWatch
Nov-07-16 04:04PM  Concordia, Vodafone in Mondays 52-Week Low Club at 24/7 Wall St.
03:35PM  World Leader in Diabetes Medication Hits 2-Year Low
11:56AM  Buy Health Care Now? It All Depends on the Election
Nov-05-16 11:01AM  Bernie Sanders Seeks DOJ Drug Probe (LLY, SNY) at Investopedia
Nov-04-16 08:04AM  What Do Analysts Recommend for Novo?
Nov-03-16 11:09AM  Roche's Haemophilia Drug Difficulties Has Rivals Looking for an Edge
11:04AM  How Did Novos Biopharmaceuticals Segment Perform in 3Q16?
10:04AM  How Tresiba Helps Novo Achieve Its Growth Targets
08:04AM  Victoza Dominates Global GLP-1 Class
01:00AM  Novo Braces for Threat From Roche on Blood Disorder Drugs at Bloomberg
Nov-02-16 11:04AM  Reading Novos Insulin Portfolio to Find Clues about Its Growth
10:05AM  Novos Dominance in Global Diabetes Market
08:06AM  How Much Did Novo Get from International Regions in 3Q16?
08:00AM  10 Most Successful Investors in the World at Insider Monkey
Nov-01-16 06:04PM  US Still the Largest Market for Novo Nordisk
05:04PM  Analyzing Novos Revenue Growth in 3Q16
04:26PM  Novo Nordisk A/S Plans to Innovate and Diversify to Avoid Payer Pressure at Motley Fool
03:20PM  Bernie Sanders is going after insulin makers over price hikes
02:57PM  Honing in on Novos 3Q16 Revenue and Earnings
Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity Care, and Biopharmaceuticals. The Diabetes and Obesity Care segment provides insulins, GLP-1 analog, obesity, and oral antidiabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles. The Biopharmaceuticals segment offers products in the areas of haemophilia care, growth hormone therapy, and hormone replacement therapy. The company markets and distributes its products through distributors and independent agents in North America, Europe, Japan and South Korea, China, Hong Kong, Taiwan, and other countries. Novo Nordisk A/S has a collaboration agreement with the Langer Laboratory. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.